Bildkälla: Stockfoto

IRLAB: Successfully completed first part of phase I IRL757 study - Redeye

Redeye gives a comment on today’s news that IRLAB has successfully completed the first part of the phase I trial with IRL757, targeting apathy.

Redeye gives a comment on today’s news that IRLAB has successfully completed the first part of the phase I trial with IRL757, targeting apathy.
Börsvärldens nyhetsbrev
ANNONSER